Olympus Corp

OLY1

Company Profile

  • Business description

    Olympus is a medical device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2024, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.

  • Contact

    Shinjuku Monolith
    2-3-1 Nishi-Shinjuku
    Shinjuku-ku
    Tokyo163-0914
    JPN

    T: +81 333402111

    http://www.olympus.co.jp

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 March 2025

    Employees

    29,780

Stocks News & Analysis

stocks

Investors overly negative on undervalued ASX share

Road to profitability is in sight as management continues to take the right steps.
stocks

Reporting season preview: February 2025

As of Wednesday, 24 companies under coverage have reported; you’ll find our analysis throughout this issue.
stocks

Signs of a turnaround for undervalued ASX share

Market likes the payoff from early efforts at reining in costs.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,811.9013.20-0.15%
CAC 408,186.387.840.10%
DAX 4022,715.25201.830.90%
Dow JONES (US)44,546.08165.35-0.37%
FTSE 1008,753.2520.790.24%
HKSE22,616.234.10-0.02%
NASDAQ20,026.7781.130.41%
Nikkei 22539,174.2524.820.06%
NZX 50 Index13,068.9379.750.61%
S&P 5006,114.630.44-0.01%
S&P/ASX 2008,537.1018.70-0.22%
SSE Composite Index3,355.839.110.27%

Market Movers